This ticker has not been starred yet ADMA Adma Biologics, Inc.
Biological Products (no Diagnostic Substances)
Book value per $ invested $ 0.16
Leverage 23.54%
Market Cap $ 3.0B
PE 20.51
Dividend Yield 0.00%
Profit $ 147.1m
Margin 28.94%

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.

Subscribe Now For Access - Only $1.99 Per Month